This research constructs a necroptosis-related lncRNA signature for predicting outcomes in gastrointestinal cancer, highlighting immune landscape implications.
Key Points
The necro-lnc score significantly predicts prognosis in gastrointestinal cancer patients, identifying those at high risk.
Statistically valid results from survival analysis demonstrated that high necro-lnc scores correlate with poorer patient outcomes.
Through extensive methodologies like Cox regression and GSEA, this study validated the prognostic capability of the necro-lnc score.
By distinguishing between hot and cold tumors, the necro-lnc score aids in selecting optimal treatment strategies for GI cancer patients.